Novavax submits COVID-19 vaccine for Health Canada approval
BNN Bloomberg
Biotechnology company Novavax Inc. says it has submitted its COVID-19 vaccine for approval in Canada, opening the prospect of another product on the country's vaccine market.
More Related News